» Authors » Zoltan Ungvari

Zoltan Ungvari

Explore the profile of Zoltan Ungvari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 316
Citations 14878
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mozes N, Arva D, Major D, Fekete M, Dosa N, Lehoczki A, et al.
Geroscience . 2025 Mar; PMID: 40088392
Europe is experiencing a significant demographic shift, with aging populations posing economic and social challenges due to increased healthcare costs and a higher prevalence of age-related diseases. Hungary, in particular,...
2.
Ungvari Z, Fekete M, Lehoczki A, Munkacsy G, Fekete J, Zabo V, et al.
Geroscience . 2025 Mar; PMID: 40072786
The link between abnormal sleep duration and stroke outcomes remains contentious. This meta-analysis quantifies how both short and long sleep durations impact stroke incidence and mortality. A comprehensive search was...
3.
Ungvari Z, Fekete M, Varga P, Fekete J, Lehoczki A, Buda A, et al.
Geroscience . 2025 Mar; PMID: 40072785
Sleep duration is a crucial factor influencing health outcomes, yet its relationship with mortality remains debated. In this meta-analysis, we aimed to investigate the association between short and long sleep...
4.
Patai R, Csik B, Nyul-Toth A, Gulej R, Vali Kordestan K, Chandragiri S, et al.
Geroscience . 2025 Feb; PMID: 39982666
Chemotherapy-related cognitive impairment, commonly referred to as "chemobrain," significantly affects cancer survivors' quality of life, yet its underlying mechanisms remain unclear. Most chemotherapeutic agents cannot cross the blood-brain barrier (BBB),...
5.
Csik B, Vali Kordestan K, Gulej R, Patai R, Nyul-Toth A, Shanmugarama S, et al.
Geroscience . 2025 Feb; PMID: 39976845
The increasing number of cancer survivors has brought heightened attention to the side effects of cancer therapies, including chemotherapy-related cognitive impairment (CRCI, commonly referred to as "chemobrain"). Cisplatin and methotrexate,...
6.
Patai R, Kiss T, Gulej R, Nyul-Toth A, Csik B, Chandragiri S, et al.
Geroscience . 2025 Feb; PMID: 39976844
Chemotherapy-induced cognitive impairment (CICI), commonly referred to as "chemobrain," is a frequent and debilitating side effect experienced by cancer survivors treated with paclitaxel (PTX). Preclinical models have shown that PTX...
7.
Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M, et al.
Nat Rev Cardiol . 2025 Feb; PMID: 39972009
Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only...
8.
Negri S, Reyff Z, Troyano-Rodriguez E, Milan M, Ihuoma J, Tavakol S, et al.
Ageing Res Rev . 2025 Jan; 104:102672. PMID: 39884362
Endothelial colony-forming cells (ECFCs), a unique endothelial progenitor subset, are essential for vascular integrity and repair, providing significant regenerative potential. Recent studies highlight their role in cerebrovascular aging, particularly in...
9.
Kovacs N, Biro E, Piko P, Ungvari Z, Adany R
Geroscience . 2025 Jan; PMID: 39873922
A healthy diet is a key determinant of successful aging. However, the psychological, social, and physiological changes associated with ageing often disrupt dietary behaviours. Hungary has one of the highest...
10.
Fekete M, Varga P, Ungvari Z, Fekete J, Buda A, Szappanos A, et al.
Geroscience . 2025 Jan; PMID: 39797935
Age-related cognitive impairment and dementia pose a significant global health, social, and economic challenge. While Alzheimer's disease (AD) has historically been viewed as the leading cause of dementia, recent evidence...